| Literature DB >> 24812137 |
James L Mohler, Philip W Kantoff, Andrew J Armstrong, Robert R Bahnson, Michael Cohen, Anthony Victor D'Amico, James A Eastham, Charles A Enke, Thomas A Farrington, Celestia S Higano, Eric Mark Horwitz, Christopher J Kane, Mark H Kawachi, Michael Kuettel, Timothy M Kuzel, Richard J Lee, Arnold W Malcolm, David Miller, Elizabeth R Plimack, Julio M Pow-Sang, David Raben, Sylvia Richey, Mack Roach, Eric Rohren, Stan Rosenfeld, Edward Schaeffer, Eric J Small, Guru Sonpavde, Sandy Srinivas, Cy Stein, Seth A Strope, Jonathan Tward, Dorothy A Shead, Maria Ho.
Abstract
Prostate cancer has surpassed lung cancer as the most common cancer in men in the United States. The NCCN Guidelines for Prostate Cancer provide multidisciplinary recommendations on the clinical management of patients with prostate cancer based on clinical evidence and expert consensus. NCCN Panel guidance on treatment decisions for patients with localized disease is represented in this version. Significant updates for early disease include distinction between active surveillance and observation, a new section on principles of imaging, and revisions to radiation recommendations. The full version of these guidelines, including treatment of patients with advanced disease, can be found online at the NCCN website.Entities:
Mesh：
Year: 2014 PMID： 24812137 DOI： 10.6004/jnccn.2014.0072
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908